Cover Image

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

Mikhail Sergeevich Zastrozhin,1,2 Vadim Markovich Brodyansky,3 Valentin Yurievich Skryabin,4 Elena Anatolievna Grishina,5 Dmitry Vladimirovich Ivashchenko,5 Kristina Anatolievna Ryzhikova,5 Ludmila Mikhaylovna Savchenko,1 Alexander Olegovich Kibitov,3 Evgeny Alekseevich Bryun,1,4 Dmitry Alekseevich...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zastrozhin MS (Author), Brodyansky VM (Author), Skryabin VY (Author), Grishina EA (Author), Ivashchenko DV (Author), Ryzhikova KA (Author), Savchenko LM (Author), Kibitov AO (Author), Bryun EA (Author), Sychev DA (Author)
Format:	Book
Published:	Dove Medical Press, 2017-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction
by: Zastrozhin MS, et al.
Published: (2017)

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction
by: Sychev DA, et al.
Published: (2016)

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder
by: Zastrozhin MS, et al.
Published: (2018)

THE INVESTIGATION OF INFLUENCE OF GENETIC PROFILE ON THE EFFICACY AND SAFETY OF HALOPERIDOL IN PATIENTS WITH ALCOHOL DEPENDENCE
by: M. S. Zastrozhin, et al.
Published: (2016)

Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients
by: Denisenko NP, et al.
Published: (2017)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018)

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
by: Sychev DA, et al.
Published: (2020)

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
by: Rytkin E, et al.
Published: (2017)

Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
by: Sychev DA, et al.
Published: (2017)

Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke
by: Kryukov AV, et al.
Published: (2018)

The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty
by: Sychev DA, et al.
Published: (2018)

The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum]
by: Sychev DA, et al.
Published: (2018)

Effects of ABCB1 rs1045642 polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I–II hypertension
by: Sychev D, et al.
Published: (2018)

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects
by: Dorofeeva MN, et al.
Published: (2019)

RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL
by: V. V. Arkhipov, et al.
Published: (2018)

Urticaria and angioedema associated with haloperidol
by: Manisha Balai, et al.
Published: (2017)

Pimozide cf. Haloperidol in Tourette Syndrome
by: J Gordon Millichap
Published: (1997)

CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome
by: Mirzaev KB, et al.
Published: (2017)

Haloperidol for Pain Management: A Narrative Review
by: Carlos J. Roldan, et al.
Published: (2024)

Divergent Effects of Haloperidol on Motor Versus Spatial Functions
by: Robert Lalonde, et al.
Published: (2017)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
by: Letao Li, et al.
Published: (2022)

Influence of <i>ABCB1</i> <i>3435C>T</i> polymorphism on methotrexate safety in patients with psoriasis
by: Alexey A. Kubanov, et al.
Published: (2023)

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity
by: Walaa Yehia Abdelzaher, et al.
Published: (2023)

Testosterone Replacement Attenuates Haloperidol-Induced Catalepsy in Male Rats
by: Naime Majidi Zolbanin, et al.
Published: (2014)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
by: Aya M. Eisa, et al.
Published: (2022)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
by: Jin Lu, et al.
Published: (2020)

Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin
by: A. A. Kachanova, et al.
Published: (2021)

IMPACT OF ABCB1 AND CES1 GENETIC POLYMORPHISMS ON TROUGH STEADY-STATE DABIGATRAN CONCENTRATIONS IN PATIENTS AFTER ENDOPROSTHESIS OF KNIFE JOIN
by: D. A. Sychev, et al.
Published: (2018)

Determination of compatibility and stability of haloperidol and morphine mixtures used in palliative care
by: Espinosa Bosch María, et al.
Published: (2018)

Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures
by: Gabriel Estan-Cerezo, et al.

Cataleptogenic Effect of Haloperidol Formulated in Water-Soluble Calixarene-Based Nanoparticles
by: Nadezda E. Kashapova, et al.
Published: (2023)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
by: Eric Rytkin, et al.
Published: (2023)

A study of personality of leader and style of his co-operation in sporting command
by: Smolar I.I, et al.
Published: (2012)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
by: Keserla Bhavani, et al.
Published: (2023)

Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma
by: Hironao Okubo, et al.
Published: (2022)

N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells
by: Ting Sun, et al.
Published: (2018)

Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
by: Maneeton B, et al.
Published: (2013)

Antiparkinsonian effect of Nutmeg ethanolic extract (Myristica fragrans Houtt.) in haloperidol-induced Mice
by: Dwi Hadi Setya Palupi, et al.
Published: (2024)

Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction
by: Yasuharu Shinoda, et al.
Published: (2016)

Haloperidol affects coupling between QT and RR intervals in guinea pig isolated heart
by: Petr Vesely, et al.
Published: (2019)